Brookline analyst Kemp Dolliver downgraded Eyenovia (EYEN) to Hold from Buy without a price target following the CHAPERONE study failure.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks